Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Chimerix Cuts 26 Jobs To Preserve Cash

This article was originally published in Scrip

Executive Summary

Chimerix Inc. cut 20% of its workforce, or 26 jobs, to preserve $342.9m in cash while the company reevaluates the development of lead antiviral drug candidate brincidofovir for the prevention or treatment of cytomegalovirus (CMV) and other DNA viral infections in transplant patients.